These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33434272)

  • 21. Bioinformatics analysis for the identification of key genes and long non-coding RNAs related to bone metastasis in breast cancer.
    Teng X; Yang T; Huang W; Li W; Zhou L; Wang Z; Feng Y; Zhang J; Yin X; Wang P; Li G; Yu H; Chen Z; Fan D
    Aging (Albany NY); 2021 Jul; 13(13):17302-17315. PubMed ID: 34226298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer driver drug interaction explorer.
    Hartung M; Anastasi E; Mamdouh ZM; Nogales C; Schmidt HHHW; Baumbach J; Zolotareva O; List M
    Nucleic Acids Res; 2022 Jul; 50(W1):W138-W144. PubMed ID: 35580047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Network control principles for identifying personalized driver genes in cancer.
    Guo WF; Zhang SW; Zeng T; Akutsu T; Chen L
    Brief Bioinform; 2020 Sep; 21(5):1641-1662. PubMed ID: 31711128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Integrative Pharmacogenomic Approach Identifies Two-drug Combination Therapies for Personalized Cancer Medicine.
    Liu Y; Fei T; Zheng X; Brown M; Zhang P; Liu XS; Wang H
    Sci Rep; 2016 Feb; 6():22120. PubMed ID: 26916442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel individualized drug repositioning approach for predicting personalized candidate drugs for type 1 diabetes mellitus.
    Zheng H
    Stat Appl Genet Mol Biol; 2019 Jul; 18(5):. PubMed ID: 31287801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coupled immune stratification and identification of therapeutic candidates in patients with lung adenocarcinoma.
    Hu W; Wang G; Chen Y; Yarmus LB; Liu B; Wan Y
    Aging (Albany NY); 2020 Aug; 12(16):16514-16538. PubMed ID: 32855362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
    Zhang W; Wang SL
    Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms.
    Zhang J; Zhang S
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(3):988-998. PubMed ID: 28113329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PenDA, a rank-based method for personalized differential analysis: Application to lung cancer.
    Richard M; Decamps C; Chuffart F; Brambilla E; Rousseaux S; Khochbin S; Jost D
    PLoS Comput Biol; 2020 May; 16(5):e1007869. PubMed ID: 32392248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Personalized therapy of lung cancer - current standard and future challenges].
    Riedel R; Wolf J
    Dtsch Med Wochenschr; 2017 Nov; 142(22):1660-1668. PubMed ID: 29078211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A data-driven interactome of synergistic genes improves network-based cancer outcome prediction.
    Allahyar A; Ubels J; de Ridder J
    PLoS Comput Biol; 2019 Feb; 15(2):e1006657. PubMed ID: 30726216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cooperative driver pathway discovery via fusion of multi-relational data of genes, miRNAs and pathways.
    Wang J; Yang Z; Domeniconi C; Zhang X; Yu G
    Brief Bioinform; 2021 Mar; 22(2):1984-1999. PubMed ID: 32103253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination prediction.
    Huang L; Brunell D; Stephan C; Mancuso J; Yu X; He B; Thompson TC; Zinner R; Kim J; Davies P; Wong STC
    Bioinformatics; 2019 Oct; 35(19):3709-3717. PubMed ID: 30768150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug repurposing for personalized medicine.
    Hora J; Rambhia N; Mani I
    Prog Mol Biol Transl Sci; 2024; 207():107-122. PubMed ID: 38942534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.
    Berlow NE; Rikhi R; Geltzeiler M; Abraham J; Svalina MN; Davis LE; Wise E; Mancini M; Noujaim J; Mansoor A; Quist MJ; Matlock KL; Goros MW; Hernandez BS; Doung YC; Thway K; Tsukahara T; Nishio J; Huang ET; Airhart S; Bult CJ; Gandour-Edwards R; Maki RG; Jones RL; Michalek JE; Milovancev M; Ghosh S; Pal R; Keller C
    BMC Cancer; 2019 Jun; 19(1):593. PubMed ID: 31208434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DRdriver: identifying drug resistance driver genes using individual-specific gene regulatory network.
    Huang YE; Zhou S; Liu H; Zhou X; Yuan M; Hou F; Chen S; Chen J; Wang L; Jiang W
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36869849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping.
    Wen Q; Kim CS; Hamilton PW; Zhang SD
    BMC Bioinformatics; 2016 May; 17(1):211. PubMed ID: 27170106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precision medicine for suicidality: from universality to subtypes and personalization.
    Niculescu AB; Le-Niculescu H; Levey DF; Phalen PL; Dainton HL; Roseberry K; Niculescu EM; Niezer JO; Williams A; Graham DL; Jones TJ; Venugopal V; Ballew A; Yard M; Gelbart T; Kurian SM; Shekhar A; Schork NJ; Sandusky GE; Salomon DR
    Mol Psychiatry; 2017 Sep; 22(9):1250-1273. PubMed ID: 28809398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovering novel cancer bio-markers in acquired lapatinib resistance using Bayesian methods.
    Azad AKM; Alyami SA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33857297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer.
    Kwon OS; Lee H; Kong HJ; Kwon EJ; Park JE; Lee W; Kang S; Kim M; Kim W; Cha HJ
    Oncogene; 2020 Jun; 39(23):4567-4580. PubMed ID: 32388539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.